Baseline demographic comparison of the AC and AP cohorts
Entire cohort (N=26) | Full (n=4) | Prophylactic+AP (n=10) | Prophylactic (n=8) | None (n=4) | |
Demographics and clinical variables | |||||
Age (years) | 26 (16–51) | 24 (22–26) | 25 (16–57) | 29 (20–51) | 24 (16–28) |
Male (%) | 26 (100) | 4 (100) | 10 (100) | 8 (100) | 4 (100) |
BMI (kg/m2) | 24.4 (19.7–45.6) | 24.4 (19.9–30.9) | 26.3 (19.7–45.6) | 22.3 (18.9–47.0) | 24.4 (23.6–28.1) |
Penetrating (%) | 24 (92) | 4 (100) | 9 (90) | 9 (100) | 3 (75) |
ISS | 22 (9–38) | 21 (10–34) | 22 (9–34) | 18 (9–38) | 27 (9–43) |
AIS score of abdomen | 4 (3–5) | 4 (3–5) | 4 (3–5) | 4 (3–5) | 3 (3–4) |
Trauma exsanguination protocol (%) | 17 (71), n=24 | 3 (75) | 6 (67), n=9 | 5 (71), n=7 | 3 (75) |
Operative management | |||||
Surgical intervention (%) | 24 (92) | 4 (100) | 9 (90) | 9 (100)* | 3 (75) |
Postoperative outcomes | |||||
IVC filter (%) | 5 (19) | 0 (0) | 2 (20) | 2 (22) | 1 (25) |
Mortality (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
All values are n (%) or median (IQR).
There was no significant difference between the treatment groups with regard to baseline demographics.
*One patient required surgical intervention, but the retroperitoneum was not explored.
AC, anticoagulation; AIS, Abbreviated Injury Scale; AP, antiplatelet; BMI, body mass index; ISS, Injury Severity Score; IVC, inferior vena cava.